Communiqués

28/03/24 PSYC Names Daniel Jaros as Interim CEO, Retires $300K+ Debt AQ
13/03/24 PSYC Begins Business Overhaul Process with Consolidation of 10 Previously Issued Convertible Debentures  AQ
08/11/23 PSYC’s CEO to Moderate Panel at The Cannabis & Psychedelics Investment Summit Hosted by Kahner Global AQ
04/10/23 PSYC’s Psychedelic Spotlight to be Media Partner for 2023 reMind Psychedelic Business Forum AQ
31/08/23 PSYC Acquires Stock Day Media to Help Bolster Revenue Production Capacity AQ
29/08/23 PSYC Enters Strategic Partnership with Target Media to Help Accelerate Audience and Revenue Growth Opportunities  AQ
06/06/23 PSYC’s Psychedelic Spotlight Continues Ascent as a Top-Ranking Multimedia Platform for the Psychedelics Sector AQ
19/05/23 PSYC Corporation Discusses Growth Strategy and Future OTCQB Uplist with The Stock Day Podcast NE
10/05/23 Spotlight Media Corporation Discusses Launch of Bonfire Platform and Its Revenue Potential with The Stock Day Podcast NE
04/05/23 PSYC Corporation Discusses 1.3M Monthly Viewership Record for Psychedelic Spotlight Website & Launch of PSYC Taboo Video Series with The Stock Day Podcast NE
27/04/23 PSYC Explores the Boundaries of Psychedelics and Society with New Video Series, “PSYC Taboo” AQ
12/04/23 PSYC Set to Relaunch Bonfire with “Psychedelics for Beginners” Online Course AQ
05/04/23 PSYC’s Psychedelic Spotlight Closes Strong Q1 With New KPI Records in March AQ
29/03/23 PSYC’s CEO to Moderate Panel at Film Screening for ESPN’s Upcoming Documentary, "Peace of Mind" AQ
15/03/23 PSYC Maintains Focus on Building Path Towards Intended OTCQB Up List AQ
16/02/23 PSYC Corporation Discusses Significance of Psychedelic Spotlight Metrics and 2023 Goals with The Stock Day Podcast NE
31/01/23 PSYC Provides Shareholders with Key Corporate Updates and Highlights Objectives for 2023 AQ
13/12/22 PSYC Provides Shareholders with a Year-End Company Review for 2022 GL
02/12/22 PSYC Corporation Discusses Its Diversification and Growth Strategy with The Stock Day Podcast NE
13/10/22 Silo Pharma Stock Higher After Investors Appraise Innovative Treatment For Nerve Pain And Neurological Disorders ($SILO) AQ
13/10/22 PSYC’s Spotlight Media Highlights Revenue Growth and Other Operational Achievements Met in Q3 AQ
10/10/22 Silo Pharma's Mission To Merge Traditional Pharmaceuticals With Psychedelic Compounds Can Be A Treatment Game-Changer For Neurological Disorders ($SILO) AQ
03/10/22 PSYC Corporation Discusses Significance of Expansion into Cannabis and Precious Metals Sectors with The Stock Day Podcast NE
22/09/22 PSYC’s Spotlight Media Corp to Host MJBizCon Kickoff Party at Brooklyn Bowl Las Vegas  AQ
20/09/22 PSYC Completes Acquisition of Media Assets from Technical420, LLC AQ
Aucun résultat pour cette recherche